Filed: 2/3/2026ACC: 0001754960-26-000146
📋 What this filing means
BML CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $115.69M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$115.69M
Total AUM (reported)
34.51M
Total Shares
Allocation by class
COM$89.84M77.7%
COM NEW$22.68M19.6%
CL A$2.02M1.7%
SHS$1.15M1.0%
Portfolio Concentration
Top 3$78.66M68.0%
4–10$31.94M27.6%
11–25$5.09M4.4%
Top 3 weight
68.0%
Top 10 weight
95.6%
Voting Authority Distribution
Total shares with voting rights: 34.51M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
34.51M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings16
Rows:
ACLARIS THERAPEUTICS INC
SOLEShares14.25M
TypeSH
Market value$42.89M
37.08%
Sole
0.00
Shared
0.00
None
14.25M
ATEA PHARMACEUTICALS INC
SOLEShares7.49M
TypeSH
Market value$26.74M
23.11%
Sole
0.00
Shared
0.00
None
7.49M
ORAMED PHARMACEUTICALS INC
SOLEShares3.17M
TypeSH
Market value$9.03M
7.80%
Sole
0.00
Shared
0.00
None
3.17M
INSTIL BIO INC
SOLEShares645.60K
TypeSH
Market value$7.10M
6.14%
Sole
0.00
Shared
0.00
None
645.60K
PMV PHARMACEUTICALS INC
SOLEShares5.29M
TypeSH
Market value$6.62M
5.72%
Sole
0.00
Shared
0.00
None
5.29M
CARMAX INC
SOLEShares155K
TypeSH
Market value$5.99M
5.18%
Sole
0.00
Shared
0.00
None
155K
KEZAR LIFE SCIENCES INC
SOLEShares720.79K
TypeSH
Market value$4.53M
3.92%
Sole
0.00
Shared
0.00
None
720.79K
TARGET CORP
SOLEShares37.50K
TypeSH
Market value$3.67M
3.17%
Sole
0.00
Shared
0.00
None
37.50K
CARVANA CO
SOLEShares150.00
TypeSH
Market value$2.02M
1.74%
Sole
0.00
Shared
0.00
None
150.00
OUTSET MED INC
SOLEShares543.18K
TypeSH
Market value$2.02M
1.74%
Sole
0.00
Shared
0.00
None
543.18K
PLIANT THERAPEUTICS INC
SOLEShares1.55M
TypeSH
Market value$1.89M
1.63%
Sole
0.00
Shared
0.00
None
1.55M
IMAGENEBIO INC
SOLEShares177.03K
TypeSH
Market value$1.22M
1.06%
Sole
0.00
Shared
0.00
None
177.03K
CONNECT BIOPHARMA HLDGS LTD
SOLEShares408.89K
TypeSH
Market value$1.15M
1.00%
Sole
0.00
Shared
0.00
None
408.89K
WALMART INC
SOLEShares335.00
TypeSH
Market value$492.4K
0.43%
Sole
0.00
Shared
0.00
None
335.00
TESLA INC
SOLEShares1K
TypeSH
Market value$205.0K
0.18%
Sole
0.00
Shared
0.00
None
1K
LISATA THERAPEUTICS INC
SOLEShares73.35K
TypeSH
Market value$136.4K
0.12%
Sole
0.00
Shared
0.00
None
73.35K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACLARIS THERAPEUTICS INCSOLE | COM | 14.25M | SH | $42.89M 37.08% | 0.00 | 0.00 | 14.25M |
ATEA PHARMACEUTICALS INCSOLE | COM | 7.49M | SH | $26.74M 23.11% | 0.00 | 0.00 | 7.49M |
ORAMED PHARMACEUTICALS INCSOLE | COM NEW | 3.17M | SH | $9.03M 7.80% | 0.00 | 0.00 | 3.17M |
INSTIL BIO INCSOLE | COM NEW | 645.60K | SH | $7.10M 6.14% | 0.00 | 0.00 | 645.60K |
PMV PHARMACEUTICALS INCSOLE | COM | 5.29M | SH | $6.62M 5.72% | 0.00 | 0.00 | 5.29M |
CARMAX INCSOLE | COM | 155K | SH | $5.99M 5.18% | 0.00 | 0.00 | 155K |
KEZAR LIFE SCIENCES INCSOLE | COM NEW | 720.79K | SH | $4.53M 3.92% | 0.00 | 0.00 | 720.79K |
TARGET CORPSOLE | COM | 37.50K | SH | $3.67M 3.17% | 0.00 | 0.00 | 37.50K |
CARVANA COSOLE | CL A | 150.00 | SH | $2.02M 1.74% | 0.00 | 0.00 | 150.00 |
OUTSET MED INCSOLE | COM NEW | 543.18K | SH | $2.02M 1.74% | 0.00 | 0.00 | 543.18K |
PLIANT THERAPEUTICS INCSOLE | COM | 1.55M | SH | $1.89M 1.63% | 0.00 | 0.00 | 1.55M |
IMAGENEBIO INCSOLE | COM | 177.03K | SH | $1.22M 1.06% | 0.00 | 0.00 | 177.03K |
CONNECT BIOPHARMA HLDGS LTDSOLE | SHS | 408.89K | SH | $1.15M 1.00% | 0.00 | 0.00 | 408.89K |
WALMART INCSOLE | COM | 335.00 | SH | $492.4K 0.43% | 0.00 | 0.00 | 335.00 |
TESLA INCSOLE | COM | 1K | SH | $205.0K 0.18% | 0.00 | 0.00 | 1K |
LISATA THERAPEUTICS INCSOLE | COM | 73.35K | SH | $136.4K 0.12% | 0.00 | 0.00 | 73.35K |